Abiomed Inc (NASDAQ:ABMD)

223.23
Delayed Data
As of Nov 15
 +2.28 / +1.03%
Today’s Change
155.02
Today|||52-Week Range
364.31
-31.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

2019
Revenue and IncomeNet Revenues329.5M445.3M593.7M769.4M
 
 
 
 
 
Cost of Goods Sold47.1M64.4M87.6M115.4M
 
 
 
 
 
Depreciation And Amortization3.3M6.2M11.0M14.1M
 
 
 
 
 
 
Operating ExpensesGross Income279.1M374.7M495.2M639.9M
 
 
 
 
 
General Expenses213.0M282.9M336.7M416.0M
 
 
 
 
 
Research And Development48.7M64.8M74.0M94.4M
 
 
 
 
 
Total Operating Expenses263.4M353.6M435.3M545.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income66.2M91.7M158.5M223.9M
 
 
 
 
 
Extraordinary Credit0.000.000.0032.1M
 
 
Extraordinary Charge-1.1M-1.6M-1.3M--
 
 
 
 
Other Expenses339.0K-349.0K-388.0K-818.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income65.8M91.3M160.4M263.4M
 
 
 
 
 
Income Taxes-27.7M-39.2M-48.3M-4.3M
 
 
 
 
 
Net Income38.1M52.1M112.2M259.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.2M43.2M44.2M44.9M
 
 
 
 
 
Shares To Calculate EPS Diluted44.9M44.7M45.8M46.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.85$1.17$2.45$5.61
 
 
 
 
 
EPS Diluted$0.85$1.17$2.45$5.61